Screening of Biomarkers and Related Mechanisms for RIX — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Screening of Biomarkers and Related Mechanisms for RIX — Stella

Home/Xerostomia Due to Radiotherapy (Disorder)/

View on ClinicalTrials.gov

Recruiting

Back to Xerostomia Due to Radiotherapy (Disorder) trials

Trial locations(4 sites)

China

The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu

Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu

Jiangsu Cancer Hospital, Nanjing, Jiangsu

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang

Key details

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators

The Tumor Hospital of Jiangsu Province, The First Affiliated Hospital with Nanjing Medical University

Enrollment target

~126 participants

Started

May 2024

Primary completion

July 2026

Age range

18 Years – 75 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.